Abstract
Background: Contrast‐induced nephropathy is one of the common causes of acute renal insufficiency after cardiovascular procedures.
Hypothesis: The objective of this paper was to analyze the published data on the usefulness of N‐acetylcysteine in the prevention of contrast‐induced nephropathy after these procedures.
Methods: Trials were selected if they were prospective, randomized, controlled, had selected patients with impaired renal function, used low‐osmolality, nonionic contrast media intra‐arterially, administered a total of four doses of N‐acetyl‐cysteine in addition to intravenous saline hydration, and had contrast‐induced nephropathy as their primary outcome. Contrast‐induced nephropathy was defined as an increase in serum creatinine concentration by > 0.5 mg/dl or a 25% increase above baseline at or within 48 h post procedure. Meta‐analysis was performed using the Fisher's Combined Test with a measure of effect size. The magnitude of the N‐acetyl‐cysteine effect was estimated using random‐effects models. Homogeneity was evaluated using the chi‐square test of homogeneity and standard Q statistic. Reporting bias was explored by the Rosenthal method.
Results: The Fisher's Combined Test was significant at p < 0.005 in favor of N‐acetylcysteine. The size of the N‐acetylcysteine effect was to reduce contrast‐induced nephropathy by 20%. There was a 62% relative risk reduction in contrast‐induced nephropathy with N‐acetylcysteine using a fixed‐effects model, and a 70% relative risk reduction using the random‐effects model. In addition, we found that 27 unpublished trials showing no effects of N‐acetylcysteine would exist to overturn the combined significance of p < 0.005 of the five trials in our meta‐analysis.
Conclusion: Oral administration of N‐acetylcysteine in addition to intravenous saline hydration has a beneficial effect in the prevention of contrast‐induced nephropathy after cardiovascular procedures in patients with impaired renal function.
Keywords: N‐acetylcysteine, contrast induced nephropathy, radio contrast dyes, renal failure, coronary angiography, percutanous coronary intervention, cardiac catheterization
Full Text
The Full Text of this article is available as a PDF (26.3 KB).
References
- 1. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW: Acute renal failure after coronary intervention: Incidence, risk factors and relationship to mortality. Am J Med 1997; 103: 368–875 [DOI] [PubMed] [Google Scholar]
- 2. Burgunder JM, Varriale A, Lauterberg BH: Effect of N‐acetylcysteine on plasma cysteine and glutathione levels following paracetamol administration. Eur J Clin Pharmacol 1989; 36: 127–131 [DOI] [PubMed] [Google Scholar]
- 3. Solomon R, Werner C, Mann D, D'Elia J, Silva P: Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331: 1416–1420 [DOI] [PubMed] [Google Scholar]
- 4. Trivedi HS, Moore H, Nasr S, Aggarwal K, Agrawal A, Goel P, Hewett J: A randomized prospective trial to assess the role of saline hydration on the development of contrast nephropathy. Nephron Clin Pract 2003; 93: c29–34 [DOI] [PubMed] [Google Scholar]
- 5. Murphy SW, Barrett BJ, Parfrey PS: Contrast nephropathy. J Am Soc Nephrol 2000; 11: 177–182 [DOI] [PubMed] [Google Scholar]
- 6. Tariq M, Morais C, Sobki A, Al Sulaiman M, Al Khader A: N‐acetylcysteine attenuates cyclosporin‐induced nephrotoxicity in rats. Nephrol Dial Transplant 1999; 14: 923–929 [DOI] [PubMed] [Google Scholar]
- 7. Andrews NP, Prasad A, Quyymi AA: N‐acetylcysteine improves coronary and peripheral vascular function. J Am Coll Cardiol 2001; 37: 117–123 [DOI] [PubMed] [Google Scholar]
- 8. Zhang H, Spapen H, Nguyen DN, Rogiers P, Bakker J, Vincent JL: Effects of N‐acetylcysteine on regional blood flow during endotoxic shock. Eur Surg Res 1995; 27: 292–300 [DOI] [PubMed] [Google Scholar]
- 9. Diaz‐Sandoval LJ, Kosowsky BD, Losordo DW: Acetylcysteine to prevent angiography‐related renal tissue injury: The APART trial. Am J Cardiol 2002; 89: 356–358 [DOI] [PubMed] [Google Scholar]
- 10. Shyu KG, Cheng JJ, Kuan P: Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 2002; 40: 1383–1388 [DOI] [PubMed] [Google Scholar]
- 11. Allaqaband S, Tumuluri R, Malik AM, Gupta A, Volkert P, Shalev Y, Bajwa TK: Prospective randomized study of N‐acetylcysteine, fenoldopam, and saline for prevention of contrast agent‐induced nephropathy. Cathet Cardiovasc Interv 2002; 57: 279–283 [DOI] [PubMed] [Google Scholar]
- 12. Briguori C, Manganelli F, Scarpato P, Elia PP, Golia B, Riviezzo G, Lepore S, Librera M, Villari B, Colombo A, Ricciardelli B: Acetylcysteine and contrast agent‐associated nephrotoxicity. J Am Coll Cardiol 2002; 40: 298–303 [DOI] [PubMed] [Google Scholar]
- 13. Kay J, Chow WH, Chan TM, Lo SK, Kwok OH, Yip A, Fan K, Lee CH, Lam WF: Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention. J Am Med Assoc 2003; 289: 553–558 [DOI] [PubMed] [Google Scholar]
- 14. Hunter JE, Schmidt FL, Jackson GB: Meta‐Analysis. Cumulating Research Findings Across Studies. Beverly Hills, Calif.: Sage, 1982. [Google Scholar]
- 15. McDaniel MA, Hirsh HR, Schmidt FL, Raju NS, Hunter JE: Interpreting the results of meta‐analytic research: A comment on Schmitt, Gooding, Noe, and Kirsch (1984). Personnel Psychology 1986; 39: 141–148 [Google Scholar]
- 16. Rosenthal R: Meta‐Analytic Procedures for Social Research. Beverly Hills, Calif.: Sage, 1984. [Google Scholar]
- 17. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W: Prevention of radiographic‐contrast‐agent‐ induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180–184 [DOI] [PubMed] [Google Scholar]
- 18. Aspelin P, Aubry P, Fransson S, Strasser R, Willenbrock R, Berg KJ: Nephrotoxic effects in high‐risk patients undergoing angiography. N Engl J Med 2003; 348: 491–499 [DOI] [PubMed] [Google Scholar]
- 19. Baker CS, Wragg A, Kumar S, De Palma R, Baker LR, Knight CJ: A rapid protocol for the prevention of contrast‐induced renal dysfunction: The RAP‐PID study. J Am Coll Cardiol 2003; 41: 2114–2118 [DOI] [PubMed] [Google Scholar]